Indications |
Ophthalmic Ocular hypertension, Open-angle glaucoma Adult: As hydrochloride: 0.5% solution: 1-2 drops of in the affected eye(s) once daily; may be given bid for more severe or uncontrolled glaucoma. 0.25% solution: 1-2 drops bid. |
Contraindications |
Bronchial asthma, severe COPD; sinus bradycardia; 2nd and 3rd degree heart block; overt cardiac failure; cardiogenic shock. |
Warnings / Precautions |
Patients at risk of developing hypoglycaemia. DM. Thyrotoxicosis. Known diminished pulmonary function. Cerebrovascular insufficiency. Do not drive or operate machinery until vision is clear. Pregnancy and lactation. |
Adverse Reactions |
Ocular stinging, burning, blepharoconjunctivitis, decreased heart rate, decreased BP, iridocyclitis, headache, transient ataxia, dizziness, lethargy, decreased corneal sensitivity, tearing, visual disturbances, urticaria and pruritus. |
Drug Interactions |
Mydriasis may occur when used with epinephrine. Additive effects with catecholamine-depleting drugs e.g. reserpine. Possible AV conduction disturbances, LVF and hypotension with IV calcium antagonists. Additive prolongation of AV conduction time with digitalis and calcium antagonists. Additive hypotensive effects with phenothiazine-related agents. Additive effect with systemic β-blockers. See Below for More levobunolol Drug Interactions |
Mechanism of Actions |
Levobunolol, a nonselective β-adrenergic blocking agent, decreases IOP by reducing aqueous humour production. Onset: Within 1 hr (ophthalmic). Duration: Up to 24 hr (ophthalmic). Absorption: Rapidly and almost completely absorbed from the GI trac t (oral). Metabolism: Extensively hepatic. Excretion: Via urine as metabolites and unchanged drug. |
Storage Conditions |
Ophthalmic: Store at 15-30°C (59-86°F). |
ATC Classification |
S01ED03 - levobunolol ; Belongs to the class of beta blocking agents. Used in the treatment of glaucoma. |
Storage |
Ophthalmic: Store at 15-30°C (59-86°F). |
Available As |
|
Levobunolol
Post Review about Levobunolol Click here to cancel reply.
Levobunolol Containing Brands
Levobunolol is used in following diseases
Drug - Drug Interactions of Levobunolol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.